Home/Pipeline/MS Biomarker Research

MS Biomarker Research

Multiple Sclerosis

ResearchActive

Key Facts

Indication

Multiple Sclerosis

Phase

Research

Status

Active

Company

Rune Labs

About Rune Labs

Rune Labs is a private, San Francisco-based digital health company founded in 2018, operating at the intersection of neuroscience, AI, and data analytics. Its core offering is the StrivePD ecosystem, an FDA-cleared platform that uses the Apple Watch to collect Parkinson's symptom data, enabling personalized patient care and providing real-world datasets for clinical research. The company generates revenue by offering its StriveStudy platform and data services to life sciences companies for clinical trials, real-world evidence, and commercial support, while also serving clinicians and patients directly. Rune Labs has established key partnerships with healthcare providers like Kaiser Permanente and biotech firms like BlueRock Therapeutics.

View full company profile

Therapeutic Areas

Parkinson's Disease Multiple Sclerosis Obsessive-Compulsive Disorder Essential Tremor

Other Multiple Sclerosis Drugs

Drug	Company	Phase	Status
Mimotopes-003	Mimotopes	Preclinical	Active
SPU-16	Silo Pharma	Preclinical	Research
Electroceutical® Therapy	Endonovo Therapeutics	Research	Active
IMX39	Imunexus Therapeutics	Preclinical	Active
BTK allosteric inhibitor	Acellera	Pre-clinical	Early Hit
CLS12311	Cellerys	Phase 2	Active
Interferon-beta variants	Heligenics	Pre-clinical	Active
G-NK cells	Indapta Therapeutics	Phase 1	Active
AVT001	Avotres	Phase 2b	Active
Undisclosed MS Program	Astoria Biologica	Pre-clinical	Active
PV-3212	Provid Pharma	Pre-clinical	Active
Evobrutinib	EMD Serono	Phase 3	Active